Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?
Anti-CTLA-4 and anti-PD-1/PD-L1 immune checkpoint inhibitors are therapeutic monoclonal antibodies that do not target cancer cells but are designed to reactivate or promote antitumor immunity. Dosing and sched...